Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Material (Type I, Type II, Type III), By Product (Vials, Bottles, Ampoules), By Drug Type (Generic, Branded, Biologic), By Region, And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the pharmaceutical glass packaging market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for pharmaceutical glass packaging market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of pharmaceutical glass packaging market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Pharmaceutical Glass Packaging Market Categorization:

The pharmaceutical glass packaging market was categorized into four segments, namely material (Type I, II, III), product (Vials, Bottles, Cartridges & Syringes, Ampoules), drug type (Generic, Branded, Biologic), and region (North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa).

Segment Market Methodology:

The pharmaceutical glass packaging market was segmented into material, product, drug type, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The pharmaceutical glass packaging market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-one countries, namely, the U.S.; Canada; Mexico; Germany; the UK; France; Italy; Spain; Switzerland; Denmark; Belgium; China; India; Japan; South Korea; Australia; Southeast Asia; Brazil; Argentina; Saudi Arabia; UAE; and South Africa.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Pharmaceutical glass packaging market companies & financials:

The pharmaceutical glass packaging market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Corning Incorporated: Coring Inc. was established in 1851 and is headquartered in New York, U.S. The company is engaged in the manufacturing of specialty glass and ceramics and its business segments include display technologies, optical communications, environmental technologies, specialty materials, and life sciences, among others. The company has 98 production facilities across 17 countries. Corning Incorporated’s display technologies segment manufactures glass substrates for flat-panel liquid crystal displays (LCDs) and the optical communications segment manufactures carrier and enterprise network components for the telecommunications industry. The company’s environmental technologies segment manufactures ceramic substrates and filters for automotive and diesel emission control applications. Its specialty materials segment offers products that provide more than 150 material formulations for glass, glass ceramics, and fluoride crystals. The life sciences segment of Corning Incorporated manufactures glass and plastic labware, equipment, media, and reagents. Other important sources of revenue for the company are its pharmaceutical technologies business and non-LCD glass business.

• Nipro Corporation: The company was established in 1948 and is headquartered in Osaka, Japan. The company is involved in the manufacturing, development, and sale of pharmaceutical, medical, and glass products. The company’s product portfolio is classified into four business segments, including medical devices, pharmaceuticals, and pharma packaging, among others. Nipro Corporation’s pharma packaging segment is involved in the manufacturing of glass molding vials, ampoules, syringes, and cartridges; glass-forming machinery; glass tubes for pharmaceuticals; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging including rubber plugs. The segment accounted for 8% of total sales in the year 2019. The Pharma packaging segment of the company has a worldwide manufacturing footprint with around 16 plants across eight countries. As of 2019, the company employed approximately 29,325 personnel globally. Over the coming years, the company plans to increase its focus on the development of advanced products that meet the needs of medical professionals and patients worldwide.

• SGD S.A.: The company was established in 1955 and is headquartered in Puteaux, France. The company is primarily engaged in manufacturing glass and glassware. It produces over 2 billion vials and bottles per annum in its five manufacturing plants located in Europe and Asia. The company operates through ten sales offices and five manufacturing facilities worldwide. As of December 2019, the company employed over 3,000 personnel globally. SGD S.A. offers a broad range of sizes and finishes in Type I, II, or III, amber, and clear glass; and innovative value-added services like internal siliconization or protective plastic coatings. The company caters to a variety of applications in the pharmaceutical industry, such as injectables, infusions, oral, nasal, and health & beauty care.

• Stölzle-Oberglas GmbH: The company was established in 1871 and is headquartered in Köflach, Austria. The company manufactures high-end packaging glass containers for pharmaceuticals, perfumery and cosmetics, spirits, and food & beverages sectors. The company has six production sites in Austria, Great Britain, France, the Czech Republic, and Poland. Moreover, it has three decoration sites in Great Britain, France, and Poland, respectively. As of December 2019, Stölzle-Oberglas GmbH employed over 2,800 personnel worldwide. It manufactures 3.1 billion glass containers per year and caters to the packaging glass demand from pharma, perfumery & cosmetics, spirits, and tableware markets.

• West Pharmaceutical Services, Inc.: The company was established in 1923 and is headquartered in Pennsylvania, U.S. The company manufactures packaging components and delivery systems for injectable drugs and healthcare products. Various products offered by the company are vial containment solutions, pre-fillable systems, self-injection platforms, cartridge systems and components, reconstitution & transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing & analytical services. The key business segments of the company include proprietary products and contract-manufactured products. The company’s proprietary products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings for biologic, generic, and pharmaceutical drug customers. Its contract-manufactured products segment serves as an integrated business focused on the design, manufacture, and automated assembly of various devices, primarily for pharmaceutical, diagnostic, and medical device customers.

• Schott AG: The company was established in 1884 and is headquartered in Mainz, Germany. The Carl Zeiss Foundation is the sole shareholder of SCHOTT AG (Mainz, Germany) and Carl Zeiss AG (Oberkochen, Germany). The company develops and manufactures special glass, specialty materials, components, and pharmaceutical systems. The company operates through seven business segments, namely advanced optics, electronic packaging, flat glass, home tech, lighting and imaging, pharmaceutical systems, and tubing. Schott AG’s pharmaceutical systems segment manufactures pharmaceutical primary packaging and provides analytical lab services. The company offers syringes, vials, ampoules, cartridges, and special articles of tubing glass or polymer. As of 2019, the company generated 45.0% of its revenue from Europe, followed by Asia (25.0%), North America (23.0%), South America (5.0%), and Rest of the World (2.0%). As of September 2019, the company operated manufacturing sites and sales offices in more than 35 countries across Europe, Asia, North America, and South America and employed over 16,200 personnel worldwide.

• Gerresheimer AG: The company was established in 2004 and is headquartered in Düsseldorf, Germany. It operates through two business segments, namely plastics & devices, and primary packaging glass. The company’s plastics & devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syringes. Gerresheimer AG’s primary packaging glass segment focuses on the production of the packaging of glass for medicines and cosmetics, such as pharmaceutical jars, ampoules, injection vials, cartridges, perfume flacons, cream jars, and glass containers for the food & beverage industry. The company operates approximately 40 production facilities in Europe, North America, South America, and Asia. As of December 2019, the company had 9,872 employees. Pharma & healthcare application segment accounted for 81.0% of its sales generated in 2019, followed by cosmetics (13.0%), and others (6.0%). Moreover, in 2019, the plastics and devices segment accounted for 54.5% revenue share, whereas primary packaging glass accounted for 45.3% of the total revenue generated.

• Bormioli Pharma S.r.l: is headquartered in Milano, Italy, and was founded in 2017. Since 2017, the company has operated as a portfolio company of Triton, an investment firm. Bormioli Pharma offers a wide range of glass packaging for the pharmaceutical market. Its product range includes glass and plastic vials, closure systems, containers, and accessories for antibiotics, infusions, syrups, drops, pills, and reagents. Bormioli Pharma S.r.l is certified with ISO 9001:2008 and ISO 15378. It has also been awarded certification for compliance with European Directive 93/42 EEC for medical devices. The company is registered with international control bodies such as the FDA for the United States market, TPP for Canada market, and SDA for China market. The manufacturing facilities of the company include six furnaces that manufacture both tubular and molded glass packaging products. The company caters its products to several industries in the pharmaceutical, cosmetics, and food sectors. It runs five plants specialized in the manufacturing of glass and plastic packaging. Moreover, it operates through four commercial platforms and caters to products in more than 100 countries across the globe. As of 2019, the employee strength of the company was over 950 personnel.

• Shandong Medicinal Glass Co., Ltd.: The company was incorporated in 1970 and is headquartered in Zibo, China. The company is principally engaged in the manufacturing and distribution of pharmaceutical glass products. Its products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops, and plastic bottles. The company is one of the largest manufacturers of medicinal glass packaging products and butyl rubber plug products in Asia. The company sells its products to over 1000 medical enterprises in China and Taiwan. Moreover, the company exports to more than 65 countries including Korea, Pakistan, the U.S., Mexico, Spain, India, Philippines, Italy, Syria, Thailand, Vietnam, and the Middle East countries.

• Beatson Clark: The company was established in 1751 and is headquartered in South Yorkshire, UK. The company was initially involved in the manufacturing of glass containers for the pharmaceutical industry, which later diversified into food & beverage markets. The company exports approximately 20% of its products in over 60 countries globally. The company produces 514 million units of pharmaceutical glass containers annually with a capacity of 145,000 tons, as of 2018. As of December 2019, the company employed 231 personnel. Newship Group, the parent company of Beatson Clark Ltd., is a privately owned group of companies operating in the packaging, construction, engineering, and event hire markets across Europe.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Pharmaceutical Glass Packaging Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2023, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Pharmaceutical Glass Packaging Market Report Assumptions:

• The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.